Abbvie Contract MFG

Potent Drug Contract Manufacturing: How Fast Can Your HPAPI Program Reach the Clinic? Speed to clinic and speed to market are the defining competitive advantages in potent drug development — and the right contract manufacturing partner makes both achievable. AbbVie Contract Manufacturing delivers potent drug contract manufacturing and solid dose manufacturing solutions combining state-of-the-art containment technology, HPAPI expertise, cGMP-compliant potent compound manufacturing, and integrated formulation development for pharmaceutical executives and formulation scientists who cannot afford delays. From early feasibility through commercial potent solid dosage manufacturing, our contained CDMO platform accelerates timelines, protects operator safety, satisfies regulatory requirements, and transforms highly potent drug substance programs into clinical and commercial realities — faster. The Race to Clinic Starts With the Right Potent Manufacturing Partner In oncology, rare disease, a...

Proprietary Hot Melt Extrusion: Is Your Formulation Partner Truly Equipped to Solve Bioavailability? Bioavailability failure is one of the most costly obstacles in oral drug development — and hot melt extrusion is one of the most powerful tools to overcome it. AbbVie Contract Manufacturing delivers proprietary hot melt extrusion services combining advanced HME technology, amorphous solid dispersion expertise, polymer science, and cGMP-compliant formulation development for pharmaceutical executives seeking a decisive development advantage. From early feasibility through commercial HME manufacturing, our integrated CDMO platform addresses solubility enhancement, bioavailability optimization, controlled release formulation, and regulatory CMC strategy under one trusted, client-focused pharmaceutical partnership built for complex molecules and demanding timelines. The Bioavailability Problem That Is Costing Your Drug Program Nearly forty percent of new molecular entities entering developme...

Custom Active Pharmaceutical Ingredients: What Happens When Your Molecule Needs More Than a Standard CDMO? Complex drug molecules demand more than routine chemistry. AbbVie Contract Manufacturing specializes in custom active pharmaceutical ingredients development, delivering precision API synthesis, cGMP-compliant drug substance production, and comprehensive regulatory support from IND through commercial launch. Our integrated pharmaceutical CDMO capabilities — spanning API route development, process optimization, analytical method validation, and clinical-to-commercial scale-up — give pharmaceutical companies and biotech firms a decisive development advantage. This article examines how custom API programs succeed when backed by advanced process chemistry, ICH-aligned quality systems, and a client-focused manufacturing partner built for molecular complexity and regulatory confidence. When Standard API Supply Is Not Enough for Your Drug Program The custom active pharmaceutical ingredien...

Custom API Manufacturing: Is Your CDMO Truly Built for Complex Molecules? Achieving reliable custom API synthesis demands more than standard chemistry. AbbVie Contract Manufacturing delivers cGMP-compliant active pharmaceutical ingredients development — from early-stage API process development through commercial API manufacturing — combining advanced process chemistry, rigorous regulatory compliance, and client-focused quality systems. This article explores how our API synthesis capabilities, analytical characterization expertise, and ICH-aligned pharmaceutical CDMO infrastructure give pharmaceutical companies and biotech firms a measurable competitive advantage. Discover how custom API development, API scale-up, clinical API manufacturing, and drug substance development come together under one trusted contract API manufacturing partner. Why Custom API Development Demands a Specialized Partner Achieving reliable custom API synthesis stands among the most demanding challenges in mod...